{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:06:28Z","timestamp":1792717588661,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tmreviews.com","patient-research.elsevier.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.tmrv.2014.04.008","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T09:17:42Z","timestamp":1400145462000},"page":"137-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Red Blood Cell Alloimmunization Mitigation Strategies"],"prefix":"10.1016","volume":"28","author":[{"given":"Jeanne E.","family":"Hendrickson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Tormey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth H.","family":"Shaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2014.04.008_bb0005","unstructured":"Whitaker B, Hinkins S. The 2011 National Blood Collection and Utilization Survey Report. In: Department of Health and Human Services, editor.2013"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0010","series-title":"FDA","article-title":"Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2013","author":"Food and Drug Administration","year":"2014"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tmrv.2007.12.002","article-title":"Integrating molecular technologies for RBC typing and compatibility testing into blood centers and transfusion services","volume":"22","author":"Hillyer","year":"2008","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12476","article-title":"Prospects for the provision of genotyped blood for transfusion","volume":"163","author":"Denomme","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tmrv.2006.11.003","article-title":"Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines","volume":"21","author":"Josephson","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0035","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunization in sickle-cell-anemia and transfusion of racially unmatched blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0040","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1182\/blood-2008-03-146415","article-title":"Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders","volume":"112","author":"Higgins","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0045","doi-asserted-by":"crossref","first-page":"937846","DOI":"10.1155\/2013\/937846","article-title":"The association of CD81 polymorphisms with alloimmunization in sickle cell disease","volume":"2013","author":"Tatari-Calderone","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0050","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1537-2995.2008.01976.x","article-title":"Anti-\u201cMi(a)\u201d immunization is associated with HLA-DRB1*0901","volume":"49","author":"Chu","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0055","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2141.2005.05868.x","article-title":"HLA-DRB1 polymorphism is associated with Kell immunisation","volume":"132","author":"Chiaroni","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0060","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1111\/j.1537-2995.2009.02369.x","article-title":"Positive association of DRB1 04 and DRB1 15 alleles with Fya immunization in a Southern European population","volume":"49","author":"Picard","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0065","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1537-2995.2005.04366.x","article-title":"HLA-DRB1 alleles and Jk(a) immunization","volume":"45","author":"Reviron","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0070","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/j.1537-2995.2008.01801.x","article-title":"Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells","volume":"48","author":"Hendrickson","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0075","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1537-2995.2006.00946.x","article-title":"Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells","volume":"46","author":"Hendrickson","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/trf.12217","article-title":"Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies","volume":"54","author":"Stowell","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0085","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2011-09-382655","article-title":"Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs","volume":"119","author":"Smith","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0090","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1537-2995.2009.02116.x","article-title":"Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?","volume":"49","author":"Yazer","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0095","doi-asserted-by":"crossref","first-page":"717.e1","DOI":"10.1016\/j.amjmed.2011.11.028","article-title":"High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease","volume":"125","author":"Papay","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ajh.22167","article-title":"Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and beta-thalassemia major","volume":"86","author":"Bao","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.20959","article-title":"Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models","volume":"82","author":"Yu","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood.V122.21.40.40","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"122","author":"Booth","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0115","author":"JPAC\u2014Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0120","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1046\/j.1537-2995.2002.00234.x","article-title":"Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management","volume":"42","author":"Shirey","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.21307\/immunohematology-2019-364","article-title":"Transfusion practices for patients with sickle cell disease at a major academic center","volume":"22","author":"Afenyi-Annan","year":"2006","journal-title":"Immunohematology"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1537-2995.1994.34794330008.x","article-title":"Antigen-matched donor blood in the transfusion management of patients with sickle-cell disease","volume":"34","author":"Tahhan","year":"1994","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0135","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.03045.x","article-title":"Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME)","volume":"51","author":"Lasalle-Williams","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0140","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1182\/blood.V96.10.3369","article-title":"Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent","volume":"96","author":"Singer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0150","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0155","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1537-2995.2002.00029.x","article-title":"DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients","volume":"42","author":"Castilho","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5581\/1516-8484.20130012","article-title":"Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients","volume":"35","author":"da Costa","year":"2013","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.transci.2013.01.009","article-title":"Blood group genotyping in multi-transfused patients","volume":"48","author":"Bakanay","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0170","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/pbc.24530","article-title":"Alloimmunization in sickle cell anemia in the era of extended red cell typing","volume":"60","author":"O'Suoji","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4049\/jimmunol.65.5.515","article-title":"The formation of circulating antibody in the splenectomized human being following intravenous injection of heterologous erythrocytes","volume":"65","author":"Rowley","year":"1950","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0180","first-page":"909","article-title":"Effects of splenectomy on the humoral immune system. A study in neonatally and adult splenectomized mice","volume":"34","author":"Rozing","year":"1978","journal-title":"Immunology"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0185","first-page":"P1-030A","article-title":"Transfused RBCs can be immunogenic in splenectomized mice: of inflammation, adjuvants, and anamnestic responses","volume":"52","author":"Hendrickson","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0008-8749(75)90201-4","article-title":"Antibody formation in mouse bone marrow. IV. The influence of splenectomy on the bone marrow plaque-forming cell response to sheep red blood cells","volume":"19","author":"Benner","year":"1975","journal-title":"Cell Immunol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.2011.08576.x","article-title":"Red cell alloimmunization in a diverse population of transfused patients with thalassaemia","volume":"153","author":"Thompson","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0200","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/08880018.2011.568595","article-title":"Blood transfusion and alloimmunization in patients with thalassemia: multicenter study","volume":"28","author":"Azarkeivan","year":"2011","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0205","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1179\/102453309X12583347114013","article-title":"Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin","volume":"15","author":"Pahuja","year":"2010","journal-title":"Hematology"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.transci.2011.07.014","article-title":"Alloimmunization to red cells in thalassemics: emerging problem and future strategies","volume":"45","author":"Gupta","year":"2011","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0215","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1182\/blood.V97.12.3999","article-title":"Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients","volume":"97","author":"Ho","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0220","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/pbc.22327","article-title":"HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease","volume":"54","author":"McPherson","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0225","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1537-2995.1994.34794330009.x","article-title":"Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients","volume":"34","author":"Casanueva","year":"1994","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0230","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00007890-198906000-00015","article-title":"Low rate of Rhesus immunization from Rh-incompatible blood transfusions during liver and heart transplant surgery","volume":"47","author":"Ramsey","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0235","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/j.1537-2995.2009.02200.x","article-title":"The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells","volume":"49","author":"Hendrickson","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0240","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood.V120.21.843.843","article-title":"Marginal zone B cells mediate alloantibody formation to a clinically significant human RBC antigen in a murine model","volume":"120","author":"Girard-Pierce","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0245","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/j.1537-2995.2011.03550.x","article-title":"CTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice","volume":"52","author":"Gilson","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0250","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1182\/blood-2012-02-410324","article-title":"Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen","volume":"119","author":"Stephen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0255","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1537-2995.1981.21281178154.x","article-title":"Clinical and laboratory findings on two patients with naturally occurring anti-Kell agglutinins","volume":"21","author":"Judd","year":"1981","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0260","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1182\/blood-2009-08-238568","article-title":"Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope","volume":"115","author":"Hudson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0265","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00043426-199905000-00011","article-title":"Comparing alloimmunization in preterm infants after transfusion of fresh unmodified versus stored leukocyte-reduced red blood cells","volume":"21","author":"Strauss","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0270","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.molimm.2010.12.017","article-title":"Alloimmunization against RBC or PLT antigens is independent of TRIM21 expression in a murine model","volume":"48","author":"Patel","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0275","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/trf.12348","article-title":"Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention","volume":"54","author":"Vichinsky","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1423-0410.1990.tb02055.x","article-title":"Red cell alloantibodies in patients with thalassemia","volume":"58","author":"Spanos","year":"1990","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0285","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle-cell disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0290","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1537-2995.2003.00443.x","article-title":"WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization","volume":"43","author":"Blumberg","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0295","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1537-2995.2003.00390.x","article-title":"HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial","volume":"43","author":"van de Watering","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0300","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2141.2005.05408.x","article-title":"Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study","volume":"129","author":"Schonewille","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0305","first-page":"640","article-title":"Leukoreduction decreases alloimmunogenicity of transfused murine HOD RBCs","volume":"114","author":"Hendrickson","year":"2009","journal-title":"ASH Annual Meeting Abstracts"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0310","first-page":"82","article-title":"Red blood cell storage: the story so far","volume":"8","author":"D'Alessandro","year":"2010","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0315","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1537-2995.2011.03162.x","article-title":"Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity","volume":"51","author":"Hendrickson","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0320","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1537-2995.2009.02481.x","article-title":"Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen","volume":"50","author":"Hendrickson","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0325","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1111\/j.1537-2995.2011.03197.x","article-title":"Transfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cells","volume":"51","author":"Hendrickson","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0330","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1111\/trf.12106","article-title":"Addition of ascorbic acid solution to stored murine red blood cells increases posttransfusion recovery and decreases microparticles and alloimmunization","volume":"53","author":"Stowell","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0335","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1309\/AJCP2J8SVWOXRLRB","article-title":"Receipt of older RBCs does not predispose D-negative recipients to anti-D alloimmunization","volume":"134","author":"Yazer","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0340","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/trf.12156","article-title":"Effect of storage of red blood cells on alloimmunization","volume":"53","author":"Zalpuri","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0345","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1423-0410.1996.7140216.x","article-title":"A prospective study of the incidence of red cell allo-immunisation following transfusion","volume":"71","author":"Redman","year":"1996","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0350","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/j.1537-2995.2008.01815.x","article-title":"Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans","volume":"48","author":"Tormey","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0355","unstructured":"US Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2009. In: US Department of Health and Human Services, editor. Rockville 2010."},{"key":"10.1016\/j.tmrv.2014.04.008_bb0360","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1309\/AJCP47QAAXTOZEKJ","article-title":"A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease","volume":"141","author":"Harm","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0365","first-page":"225","article-title":"The persistence of red cell alloantibodies","volume":"6","author":"Reverberi","year":"2008","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0370","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1537-2995.2008.02014.x","article-title":"The persistence and evanescence of blood group alloantibodies in men","volume":"49","author":"Tormey","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0375","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/trf.12251","article-title":"Record fragmentation due to transfusion at multiple health care facilities: a risk factor for delayed hemolytic transfusion reactions","volume":"54","author":"Unni","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0380","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1537-2995.2010.02629.x","article-title":"Regional registry of patient alloantibodies: first-year experience","volume":"50","author":"Schwickerath","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0385","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1537-2995.2012.03789.x","article-title":"The immunohematologic and patient safety benefits of a centralized transfusion database","volume":"53","author":"Delaney","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0390","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1537-2995.2007.01289.x","article-title":"Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning","volume":"47","author":"Worel","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0395","doi-asserted-by":"crossref","first-page":"861","DOI":"10.5858\/arpa.2012-0154-CR","article-title":"Limiting the extent of a delayed hemolytic transfusion reaction with automated red blood cell exchange","volume":"137","author":"Tormey","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0400","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00043426-199901000-00016","article-title":"Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia","volume":"21","author":"Kalyanaraman","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0405","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1537-2995.1998.38598297215.x","article-title":"Release of mediators of systemic inflammatory response syndrome in the course of a severe delayed hemolytic transfusion reaction caused by anti-D","volume":"38","author":"von Zabern","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0410","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0955-3886(90)90015-B","article-title":"Plasma exchange in the management of delayed hemolytic transfusion reaction","volume":"11","author":"Wright","year":"1990","journal-title":"Transfus Sci"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0415","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tmrv.2009.09.006","article-title":"Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review","volume":"24","author":"Win","year":"2010","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0420","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10245330400001926","article-title":"Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease","volume":"9","author":"Win","year":"2004","journal-title":"Hematology"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0425","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21307\/immunohematology-2019-223","article-title":"Autoantibody formation after alloimmunization inducing bystander immune hemolysis","volume":"25","author":"Mota","year":"2009","journal-title":"Immunohematology"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0430","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.3324\/haematol.12074","article-title":"Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease","volume":"92","author":"Noizat-Pirenne","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0435","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1537-2995.2009.02163.x","article-title":"Clinical significance of serologic markers related to red blood cell autoantibodies production after red blood cell transfusion-severe autoimmune hemolytic anemia occurring after transfusion and alloimmunization: successful treatment with rituximab","volume":"49","author":"Sigler","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0440","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4081\/hr.2013.e11","article-title":"An attempt to induce transient immunosuppression pre-erythrocytapheresis in a girl with sickle cell disease, a history of severe delayed hemolytic transfusion reactions and need for hip prosthesis","volume":"5","author":"Cattoni","year":"2013","journal-title":"Hematol Rep"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0445","doi-asserted-by":"crossref","first-page":"307093","DOI":"10.1155\/2012\/307093","article-title":"Initiation and regulation of complement during hemolytic transfusion reactions","volume":"2012","author":"Stowell","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.tmrv.2014.04.008_bb0450","first-page":"CD008267","article-title":"Antenatal immunoglobulin for fetal red blood cell alloimmunization","volume":"5","author":"Wong","year":"2013","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796314000479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796314000479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T17:51:25Z","timestamp":1716745885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796314000479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0887796314000479"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2014.04.008","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red Blood Cell Alloimmunization Mitigation Strategies","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2014.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}